Contel Lab Profile
Contel Lab

@ContelLab

Followers
1K
Following
1K
Media
49
Statuses
667

Research Group of Maria Contel at Brooklyn College, CUNY. Synthetic and Medicinal Inorganic Chemistry.

Joined August 2019
Don't wanna be here? Send us removal request.
@ContelLab
Contel Lab
1 year
Starting on November 15th of 2024 you can follow us on Bluesky Social Media. our Lab will not use X any longer. See you!
0
0
0
@asrc_gc
CUNY ASRC
1 year
Collaboration is essential to science. It can come in the form of scientist to scientist, scientists to local community members, or monetary support from people who believe in science. If you identify as the latter, help @NanoBioNYC reach its goal. https://t.co/PjPgzSkZP2
0
3
6
@CastonguayAnnie
Annie Castonguay research
1 year
I am pleased to announce that there are now PhD positions available in the Castonguay group @inrsciences in bioorganometallic chemistry. https://t.co/ZQW5Hh2tj8 #metalsinmedicine #bioorganometallics
2
27
94
@GimenoGroup
ConchitaGimeno'sGroup_ISQCH
1 year
Excellent talk given by Prof. Maria Contel @ContelLab about “Heterometallic gold-based complexes as potential anticancer chemotherapeutics” at @icomc2024 (Agra, India). Congratulations Maria for your interesting results!!! #icomc2024
1
5
43
@ContelLab
Contel Lab
1 year
Excellent first evening at the 30th International Conference on Organometallic Chemistry in Agra, India
0
0
44
@ContelLab
Contel Lab
1 year
Maria received yesterday a Brooklyn College Award on Excellence in Scholarship and Creative Achievement. She thanks current and former members of the group, as well as collaborators!
14
3
52
@ContelLab
Contel Lab
2 years
Celebrating Dr. Jason Lewis (Memorial Sloan Kettering Cancer Center and BCCC-CURE Advisory Board Member) as the 2024 Brooklyn College Friedman Lecturer (the most prestigious lecture in the Chem. & Biochem. Dept.) @LewisLabMSKCC @BCCancerCenter @BklynCollege411 @MSKCancerCenter
1
1
28
@PSC_CUNY
PSC/CUNY
2 years
The PSC condemns in the strongest possible terms the militarized policing of campuses that is taking place across the country and in New York City, including at our own @CityCollegeNY campus last night. Full statement: https://t.co/N7NSuy0Z9c
2
54
101
@ContelLab
Contel Lab
2 years
Today we had a training on “Technology Transfer and Innovation at CUNY” organized by BCCC-CURE, ASRC-CAT, CUNY TOC, and I-CORPS. Thanks to Tavis Ezell, Neeti Mitra, Cira Cardaci, and Yuki Yen. Looking forward to future entrepreneurship efforts ! @ASRCsensorCAT; @BCCancerCenter
0
0
5
@ContelLab
Contel Lab
2 years
Brava Sherri! @smcfarla
@GasserGroup
Gasser Group
2 years
Congrats Sherri!
0
0
2
@ContelLab
Contel Lab
2 years
Join us in June of 2024 for the GRC and GRS Metals in Medicine. Exciting program!
@DuhmeKlairYork
AKDK Research Group
2 years
❗️📢❗️Excited to announce that the full programme for our Metals in Medicine GRC is now available at https://t.co/r1hE8AcEal Make sure not to miss it by applying early! Looking forward to chair together with Prof. C. J. Anderson, @ContelLab and @GasserGroup
0
4
13
@rsc_medchem
RSC Medicinal Chemistry
2 years
‼Be sure to read recent work from @LewisLabMSKCC, @ContelLab and colleagues on the development of immunoliposomes containing cytotoxic gold payloads against HER2-positive breast cancers⬇ https://t.co/PpqGAleMbL 📍 @CUNY and @MSKCancerCenter
Tweet card summary image
pubs.rsc.org
Overexpression of the human epidermal growth factor receptor 2 (HER2) is found in 20–30% of breast cancer tumors (HER2-positive breast cancers) and is associated with more aggressive onset of...
0
2
4
@ContelLab
Contel Lab
2 years
Congratulations to doctoral student Javier Lopez-Hernandez who defended his doctoral thesis yesterday! Javier worked on Pt(IV)-Au(I) anticancer agents, and synthesized many other compounds for our group. Well done doctor Lopez!
3
2
28
@CUNY
The City University of New York
2 years
As we begin the seven days of Kwanzaa, we are reminded of how the power of community, purpose and creativity can lift our University and our city. The CUNY family sends our best wishes to everyone celebrating. #HappyKwanzaa
5
12
23
@ContelLab
Contel Lab
2 years
We really enjoyed the last BCCC-CURE/Chemistry Department seminar of the year on Friday Dec 8th by Dr. Guillermo Moreno Alcántar from the Technical University of Munich. Excellent talk on supramolecular metal-based materials and their medicinal applications. Very inspiring!
0
2
16
@ContelLab
Contel Lab
2 years
Congrats to Afruja and rest of team members at BC and MSKCC! Great collaboration with the Lewis group.! Impressive results in vivo for a gold based ADC, very exciting!! ⁦@AfrujaAhad⁩ ⁦@LewisLabMSKCC⁩ ⁦@BCCancerCenter⁩ ⁦@GC_CUNY
Tweet card summary image
pubs.acs.org
Antibody–drug conjugates (ADCs) combine the selectivity of monoclonal antibodies (mAbs) with the efficacy of chemotherapeutics to target cancers without toxicity to normal tissue. Clinically, most...
7
6
36
@BCCancerCenter
Brooklyn College Cancer Center (BCCC-CURE)
2 years
Help us give BC students #CancerResearch internships, and scholarships to work with doctors & attend conferences. Donate today #CUNYTUESDAY2023 https://t.co/Rkd1mtVl1a #GivingTuesday #GivingTuesday2023 #CancerResearch #FightingCancerHelp @BklynCollege411 @BkCollegeAlumni @CUNY
0
1
0
@ContelLab
Contel Lab
2 years
An excellent book from colleagues and friends! A people’s guide to New York City
@GC_CUNY
The Graduate Center
3 years
A new book by Profs. Carolina Bank Muñoz, Penny Lewis of @CunySLU, and Emily @tumpsonmolina of @BklynCollege411 disrupts the guidebook industry by focusing on people power and social movements – even the integration fight behind the Brooklyn blackout cake https://t.co/zkoB5keVJw
0
1
3
@ContelLab
Contel Lab
2 years
Development of immunoliposomes containing cytotoxic gold payloads against HER2-positive breast cancers - RSC Medicinal Chemistry (RSC Publishing) ⁦@AfrujaAhad⁩ ⁦@LewisLabMSKCC⁩ ⁦@GC_CUNY⁩ ⁦@BCCancerCenter
pubs.rsc.org
Overexpression of the human epidermal growth factor receptor 2 (HER2) is found in 20–30% of breast cancer tumors (HER2-positive breast cancers) and is associated with more aggressive onset of...
6
2
24